GENEDRIVE DIAGNOSTICS LTD
Get an alert when GENEDRIVE DIAGNOSTICS LTD files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£1.2M
-77.4% vs 2024
Net assets
-£22M
-30.6% vs 2024
Employees
43
0% vs 2024
Profit before tax
-£5.3M
-1.2% vs 2024
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
Material uncertainty over going concern
The Directors are reasonably confident, based on the progress of these discussions, that the necessary financing will be obtained and has agreed heads of terms for a £1m loan with the parent Company's major shareholder. As at the date of approval of these financial statements, no binding agreements have been finalised. As a result, the successful completion of the financing is not wholly within the control of the Group and therefore, in conjunction with the inherent uncertainty with regards to revenue generation, represents a material uncertainty that may cast significant doubt on the Company's ability to continue as a going concern.
Net assets
2-year trend · vs Health Care median
Accounts
2-year trend · Δ = latest vs prior filed period · latest reflected 2025-06-30
| Metric | Trend | 2024-06-30 | 2025-06-30 | Δ vs prior |
|---|---|---|---|---|
| Turnover | £501,000 | £954,000 | +90.4% | |
| Operating profit | -£5,290,000 | -£5,380,000 | -1.7% | |
| Profit before tax | -£5,272,000 | -£5,337,000 | -1.2% | |
| Net profit | -£4,597,000 | -£5,142,000 | -11.9% | |
| Cash | £5,178,000 | £1,172,000 | -77.4% | |
| Total assets less current liabilities | -£16,524,000 | -£21,582,000 | -30.6% | |
| Net assets | -£16,524,000 | -£21,582,000 | -30.6% | |
| Equity | -£16,524,000 | -£21,582,000 | -30.6% | |
| Average employees | 43 | 43 | 0% | |
| Wages | £2,998,000 | £2,969,000 | -1% | |
| Directors' remuneration | £761,993 | £497,252 | -34.7% |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2024-06-30 | 2025-06-30 |
|---|---|---|---|
| Current ratio | 4.65x | 1.94x |
Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Margin ratios are hidden where reported turnover is too small relative to profit to yield a meaningful figure — typical of holding companies whose income is mostly subsidiary dividends rather than trading revenue. Sector-distribution context coming next.
Name history
Renamed 1 time since incorporation
- GENEDRIVE DIAGNOSTICS LTD 2018-06-12 → present
- EPISTEM LIMITED 2000-01-04 → 2018-06-12
Audit & accounting basis
- Accounting basis
- UK-adopted International Accounting Standards
- Reporting scope
- Standalone (parent only)
- Auditor
- RSM UK Audit LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Material uncertainty disclosed
“The Directors are reasonably confident, based on the progress of these discussions, that the necessary financing will be obtained and has agreed heads of terms for a £1m loan with the parent Company's major shareholder. As at the date of approval of these financial statements, no binding agreements have been finalised. As a result, the successful completion of the financing is not wholly within the control of the Group and therefore, in conjunction with the inherent uncertainty with regards to revenue generation, represents a material uncertainty that may cast significant doubt on the Company's ability to continue as a going concern.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
2 active · 22 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| MIELE, Gino, Dr | Director | 2023-09-11 | Jul 1970 | British |
| SHAW, Russell John | Director | 2022-03-29 | Sep 1978 | British |
Show 22 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BOOTH, Catherine, Dr | Secretary | 2002-09-18 | 2006-01-18 |
| FOWLER, Matthew John | Secretary | 2017-01-05 | 2022-03-29 |
| ROSLING, Heather Anne | Secretary | 2000-01-04 | 2000-10-17 |
| RYLANDS, Hugh John Joseph | Secretary | 2006-01-18 | 2017-01-05 |
| TSM CO SECRETARIAL SERVICES | Corporate Secretary | 2000-10-16 | 2002-09-18 |
| BOOTH, Catherine, Dr | Director | 2000-01-26 | 2018-06-08 |
| BRADY, Gerard | Director | 2002-04-23 | 2011-08-04 |
| BROWN, Allan | Director | 2014-02-01 | 2017-11-08 |
| BUDD, David | Director | 2018-06-11 | 2023-09-11 |
| CHEEK, James Bernard | Director | 2023-09-11 | 2024-08-06 |
| EVANS, David Eric | Director | 2005-06-01 | 2009-10-01 |
| FOWLER, Matthew John | Director | 2016-12-19 | 2022-03-29 |
| LAMBERT, Susan | Director | 2004-06-23 | 2005-06-30 |
| MCDONALD, Susan Rebecca | Director | 2000-09-21 | 2005-06-30 |
| MOORE, Jeffrey, Dr | Director | 2005-09-28 | 2013-10-10 |
| NOLAN, Robert Dwyer | Director | 2004-06-23 | 2009-10-01 |
| ONYETT, Richard Anthony | Director | 2006-05-01 | 2007-01-31 |
| POTTEN, Christopher, Doctor | Director | 2000-01-26 | 2009-10-01 |
| PRIOR, Michael John | Director | 2001-06-01 | 2002-07-31 |
| RYLANDS, John | Director | 2002-03-13 | 2017-01-05 |
| WALLS, Matthew Heaton | Director | 2007-03-28 | 2015-10-23 |
| MANCHESTER INNOVATION LIMITED | Corporate Director | 2000-01-04 | 2000-10-17 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Genedrive Plc | Corporate entity | Shares 75–100% | 2017-01-26 | Active |
Filing timeline
Last 20 of 164 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-01-21 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-12-22 | AA | accounts | Accounts with accounts type full | |
| 2025-02-07 | AA | accounts | Accounts with accounts type full | |
| 2025-01-21 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-08-12 | TM01 | officers | Termination director company with name termination date | |
| 2024-01-18 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-01-02 | AA | accounts | Accounts with accounts type full | |
| 2023-09-13 | TM01 | officers | Termination director company with name termination date | |
| 2023-09-13 | AP01 | officers | Appoint person director company with name date | |
| 2023-09-13 | AP01 | officers | Appoint person director company with name date | |
| 2023-03-23 | AA | accounts | Accounts with accounts type full | |
| 2023-01-20 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-04-08 | CH01 | officers | Change person director company with change date | |
| 2022-03-29 | TM01 | officers | Termination director company with name termination date | |
| 2022-03-29 | TM02 | officers | Termination secretary company with name termination date | |
| 2022-03-29 | AP01 | officers | Appoint person director company with name date | |
| 2022-01-18 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2021-11-19 | AA | accounts | Accounts with accounts type full | |
| 2021-03-25 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2020-12-15 | AA | accounts | Accounts with accounts type full |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 2
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.